Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MRI-Guided HDR Brachytherapy for Prostate Cancer

NCT00913939 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT00913939
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00913939 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MRI-Guided HDR Brachytherapy for Prostate Cancer
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Recruiting
Start date
May 31, 2009
Completion date
May 31, 2027
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients with prostate cancer